Emerald Advisors, LLC Merck & Co., Inc. Transaction History

Emerald Advisors, LLC

$774 Million
Q2 2025

A detailed history of Emerald Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Emerald Advisors, LLC holds 12,984 shares of MRK stock, worth $1.06 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

12,984

Previous 5,139 152.66%

Holding current value

$1.06 Million

Previous $461,000 122.78%

% of portfolio

0.13%

Previous 0.06%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 17, 2025	BUY	$73.47 - $87.12 $576,372 - $683,456	7,845 Added 152.66%	12,984 $1.03 Million
Q1 2025 Apr 24, 2025	BUY	$83.01 - $101.02 $94,465 - $114,960	1,138 Added 28.44%	5,139 $461,000
Q4 2024 Jan 31, 2025	BUY	$96.31 - $114.76 $1,252 - $1,491	13 Added 0.33%	4,001 $398,000
Q3 2024 Oct 31, 2024	SELL	$111.15 - $128.97 $92,699 - $107,560	-834 Reduced 17.3%	3,988 $452,000
Q2 2024 Jul 15, 2024	SELL	$123.8 - $132.96 $436,271 - $468,551	-3,524 Reduced 42.22%	4,822 $596,000
Q1 2024 Apr 25, 2024	BUY	$113.24 - $131.95 $11,890 - $13,854	105 Added 1.27%	8,346 $1.1 Million
Q4 2023 Jan 23, 2024	BUY	$100.18 - $109.02 $28,350 - $30,852	283 Added 3.56%	8,241 $898,000
Q3 2023 Oct 13, 2023	BUY	$102.95 - $114.33 $113,553 - $126,105	1,103 Added 16.09%	7,958 $819,000
Q2 2023 Aug 02, 2023	BUY	$108.61 - $118.38 $48,440 - $52,797	446 Added 6.96%	6,855 $790,000
Q1 2023 Apr 07, 2023	SELL	$102.94 - $114.86 $94,293 - $105,211	-916 Reduced 12.51%	6,409 $681,000
Q4 2022 Jan 20, 2023	SELL	$87.44 - $112.11 $108,600 - $139,240	-1,242 Reduced 14.5%	7,325 $0
Q3 2022 Oct 12, 2022	SELL	$84.53 - $94.96 $7,692 - $8,641	-91 Reduced 1.05%	8,567 $738,000
Q2 2022 Aug 01, 2022	SELL	$83.49 - $94.64 $95,429 - $108,173	-1,143 Reduced 11.66%	8,658 $789,000
Q1 2022 Apr 26, 2022	BUY	$73.51 - $82.4 $29,698 - $33,289	404 Added 4.3%	9,801 $804,000
Q4 2021 Jan 19, 2022	BUY	$72.28 - $90.54 $82,905 - $103,849	1,147 Added 13.9%	9,397 $720,000
Q3 2021 Nov 02, 2021	BUY	$71.68 - $78.83 $36,413 - $40,045	508 Added 6.56%	8,250 $620,000
Q2 2021 Aug 02, 2021	BUY	$70.31 - $77.77 $53,224 - $58,871	757 Added 10.84%	7,742 $602,000
Q1 2021 Apr 20, 2021	BUY	$68.86 - $81.11 $16,939 - $19,953	246 Added 3.65%	6,985 $538,000
Q4 2020 Feb 05, 2021	BUY	$71.77 - $79.65 $56,052 - $62,206	781 Added 13.11%	6,739 $551,000
Q3 2020 Nov 10, 2020	BUY	$73.18 - $82.95 $13,757 - $15,594	188 Added 3.26%	5,958 $494,000
Q2 2020 Aug 10, 2020	BUY	$70.42 - $80.13 $29,224 - $33,253	415 Added 7.75%	5,770 $446,000
Q1 2020 May 14, 2020	BUY	$63.36 - $87.82 $339,292 - $470,276	5,355 New	5,355 $409,000

Others Institutions Holding MRK

# of Institutions

3,882

Shares Held

1.93B

Call Options Held

25.6M

Put Options Held

24M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $207B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisors, LLC with notifications on news.

Account

Emerald Advisors, LLC Merck & Co., Inc. Transaction History